NanoVibronix Announces Completion Of Design Phase For Next-Gen PainShield And UroShield Devices, Advancing To Verification And Testing, Aiming To Lower Costs And Enhance Manufacturing

BenzingaJan 7 08:11 ET

Express News | Nanovibronix Advances Development of Painshield and Uroshield With Completion of Nextgen Prototypes

ReutersJan 7 08:04 ET

Transforming Catheter Care: NanoVibronix Completes Successful UroShield US Trial

Yahoo FinanceJan 7 05:53 ET

NanoVibronix Shares Are Trading Higher After the Company Announced the Completion of the First Phase of a Randomized Control Trial Study of UroShield.

BenzingaJan 6 12:56 ET

Reported Earlier, NanoVibronix Announces Completion Of Pilot Phase Of Clinical Study Of UroShield At The University Of Michigan; Research Expected To Advance To 'Full Study' Phase In 2025

BenzingaJan 6 12:48 ET

NanoVibronix Advances UroShield Trial and Receives Nasdaq Extension

TipRanksJan 6 08:45 ET